New York State Common Retirement Fund’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding GYRE
SS
SO
PFSRSONJ
SOADOR
AWM
SCM
GI
PWA
BFS
New York State Common Retirement Fund's GYRE Position: Q2 2026 in Review
New York State Common Retirement Fund held its Gyre Therapeutics (GYRE) position steady in Q2 2026 at 2,700 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3130.
New York State Common Retirement Fund first reported a position in GYRE in Q2 2018 and has held it in 18 quarters since. The position peaked at $154K in Q2 2018. 14 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.
- New York State Common Retirement Fund held 2,700 shares of Gyre Therapeutics worth $17.8K as of Q2 2026.
- New York State Common Retirement Fund left its Gyre Therapeutics share count unchanged in Q2 2026.
- Gyre Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3130 holding.
- New York State Common Retirement Fund first reported a position in Gyre Therapeutics in Q2 2018 and has held it in 18 quarters since.
- New York State Common Retirement Fund's Gyre Therapeutics position peaked at $154K in Q2 2018.
- 14 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.